Primary and secondary outcomes in propensity-matched cohort The rates of acute healthcare utilization, all-cause mortality, combined cardiovascular composite event outcome, and CKD progression of the two study groups are shown in Table 2A
You might be a good fit if any of these apply to you: Youre switching between GLP-1 medications: If youre moving from one GLP-1 to another (like Ozempic to Wegovy or Mounjaro to Zepbound), microdosing can make that transition smoother
Song X, Jia H, Jiang Y, Wang L, Zhang Y, Mu Y, et al
Visit help centre Online healthcare you can trust (Reviews and stats are for Phlo) 750,000+ Delivered medicines 17,500+ Deliveries per month Frequently asked questions What are injectable weight loss medications
High levels of emotional or physical stress
International Journal of Cardiology